Patient leaflet - Ivabradine 7.5 mg film-coated tablets
1. What Ivabradine is and what it is used for
Ivabradine is a heart medicine used to treat:
Symptomatic stable angina pectoris (which causes chest pain) in
adult patients whose heart rate is over or equal to 70 beats per minute. It is used in adult patients who do not tolerate or cannot take heart medicines called beta-blockers. It is also used in combination with beta-blockers in adult patients whose condition is not fully controlled with a beta-blocker.
Chronic heart failure in adult patient whose heart rate is over or
equal to 75 beats per minute. It is used in combination with standard therapy, including beta-blocker therapy or when beta-blockers are contraindicated or not tolerated. About stable angina pectoris (usually referred to as "angina"): Stable angina is a heart disease which happens when the heart does not receive enough oxygen. It usually appears between 40 and 50 years of age. The most common symptom of angina is chest pain or discomfort. Angina is more likely to happen when the heart beats faster in situations such as exercise, emotion, exposure to the cold or after eating. This increase in heart rate can cause the chest pain in people who suffer from angina.
About chronic heart failure:
Chronic heart failure is a heart disease which happens when your heart cannot pump enough blood to the rest of your body. The most common symptoms of heart failure are breathlessness, fatigue, tiredness and ankle swelling.
How does Ivabradine work?
Ivabradine mainly works by reducing the heart rate by a few beats per minute. This lowers the heart's need for oxygen especially in the situations when an angina attack is more likely to happen. In this way Ivabradine helps to control and reduce the number of angina attacks. Furthermore as elevated heart rate adversely affects the heart functioning and vital prognosis in patients with chronic heart failure, the specific heart rate lowering action of Ivabradine helps to improve the heart functioning and vital prognosis in these patients.
2. What you need to know before you take Ivabradine
Do not take Ivabradine
if you are allergic to Ivabradine or any of the other ingredients of
this medicine (listed in section 6)
if your resting heart rate before treatment is too slow (below 70
beats per minute)
if you are suffering from cardiogenic shock (a heart condition
treated in hospital)
- if you suffer from a heart rhythm disorder
- if you are having a heart attack
- if you suffer from very low blood pressure
if you suffer from unstable angina (a severe form in which chest
pain occurs very frequently and with or without exertion)
- if you have heart failure which has recently become worse;
- if your heart-beat is exclusively imposed by your pacemaker
- if you suffer from severe liver problems
if you are already taking medicines for the treatment of fungal
infections (such as ketoconazole, itraconazole), macrolide antibiotics (such as josamycin, clarithromycin, telithromycin or
erythromycin given orally), medicines to treat HIV infections (such as nelfinavir, ritonavir), nefazodone (medicine to treat depression) or diltiazem, verapamil (used for high blood pressure or angina pectoris)
- if you are a woman able to have children and not using reliable contraception
if you are pregnant or trying to become pregnant
- if you are breast-feeding.
Warnings and precautions
Talk to your doctor or pharmacist before taking Ivabradine
- if you suffer from heart rhythm disorders (such as irregular heartbeat, palpitation, increase in chest pain) or sustained atrial fibrillation (a type of irregular heartbeat), or an abnormality of electrocardiogram (ECG) called 'long QT syndrome'
- if you have symptoms such as tiredness, dizziness or shortness of breath (this could mean that your heart is slowing down too much)
- if you suffer from symptoms of atrial fibrillation (pulse rate at rest unusually high (over 110 beats per minute) or irregular, without any apparent reason, making it difficult to measure)
- if you have had a recent stroke (cerebral attack)
- if you suffer from mild to moderate low blood pressure
- if you suffer from uncontrolled blood pressure, especially after a change in your antihypertensive treatment
- if you suffer from severe heart failure or heart failure with abnormality of ECG called 'bundle branch block'
- if you suffer from chronic eye retinal disease
- if you suffer from moderate liver problems
- if you suffer from severe renal problems.
If any of the above applies to you, talk straight away to your doctor before or while taking Ivabradine
Children
Ivabradine is not intended for use in children and adolescents younger than 18 years.
Other medicines and Ivabradine
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Make sure to tell your doctor if you are taking any of the following medicines, as a dose adjustment of Ivabradine or monitoring should be required:
- fluconazole (an antifungal medicine)
- rifampicin (an antibiotic)
- barbiturates (for difficult sleeping or epilepsy)
- phenytoin (for epilepsy)
- Hypericum perforatum or St John's Wort (herbal treatment for depression)
QT prolonging medicines to treat either heart rhythm disorders or other conditions:
- quinidine, disopyramide, ibutilide, sotalol, amiodarone (to treat heart rhythm disorders)
- bepridil (to treat angina pectoris)
- certain types of medicines to treat anxiety, schizophrenia or other psychoses (such as pimozide, ziprasidone, sertindole)
- anti-malarial medicines (such as mefloquine or halofantrine)
- intravenous erythromycin (an antibiotic)
- pentamidine (an antiparasitic medicine)
- cisapride (against the gastro-oesophageal reflux)
- Some types of diuretics which may cause decrease in blood potassium level, such as furosemide, hydrochlorothiazide, indapamide (used to treat oedema, high blood pressure). Ivabradine with food and drink
Avoid grapefruit juice during treatment with Ivabradine. Pregnancy and breast-feeding and fertility
Do not take Ivabradine if you are pregnant or are planning to have a baby (see "Do not take Ivabradine").
If you are pregnant and have taken Ivabradine, talk to your doctor. Do not take Ivabradine if you are able to become pregnant unless you use reliable contraceptive measures (see "Do not take Ivabradine"). Do not take Ivabradine if you are breast-feeding (see "Do not take Ivabradine"). Talk to your doctor if you are breast-feeding or intending to breast-feed as breast-feeding should be discontinued if you take Ivabradine.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Ivabradine 5 mg Film-coated Tablets Ivabradine 7.5 mg Film-coated Tablets
Package leaflet: Information for the patient
50 mm
1226995-V1 Driving and using machines
Ivabradine may cause temporary luminous visual phenomena (a temporary brightness in the field of vision, see "Possible side effects"). If this happens to you, be careful when driving or using machines at times when there could be sudden changes in light intensity, especially when driving at night.
Ivabradine contains lactose
If you have been told by your doctor that you have intolerance to some sugars, contact your doctor before taking this medicine.
3. How to take Ivabradine
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. Ivabradine should be taken during meals.
If you are being treated for stable angina pectoris
The starting dose should not exceed one tablet of Ivabradine 5 mg twice daily. If you still have angina symptoms and if you have tolerated the 5 mg twice daily dose well, the dose may be increased. The maintenance dose should not exceed 7.5 mg twice daily. Your doctor will prescribe the right dose for you. The usual dose is one tablet in the morning and one tablet in the evening. In some cases (e.g. if you are elderly), your doctor may prescribe half the dose i.e., one half 5 mg tablet of Ivabradine 5 mg (corresponding to 2.5 mg Ivabradine) in the morning and one half 5 mg tablet in the evening. If you are being treated for chronic heart failure
The usual recommended starting dose is one tablet of Ivabradine 5 mg twice daily increasing of necessary to one tablet of Ivabradine 7.5 mg twice daily. Your doctor will decide the right dose for you. The usual dose is one tablet in the morning and one tablet in the evening. In some cases (e.g. if you are elderly), your doctor may prescribe half the dose i.e., one half 5 mg tablet of Ivabradine 5 mg (corresponding to 2.5 mg Ivabradine) in the morning and one half 5 mg tablet in the evening. If you take more Ivabradine than you should:
A large dose of Ivabradine could make you feel breathless or tired because your heart slows down too much. If this happens, contact your doctor immediately.
If you forget to take Ivabradine:
If you forget to take a dose of Ivabradine, take the next dose at the usual time. Do not take a double dose to make up for the forgotten dose. If you stop taking Ivabradine:
As the treatment for angina or chronic heart failure is usually life-long, you should discuss with your doctor before stopping this medicinal product. If you think that the effect of Ivabradine is too strong or too weak, talk to your doctor or pharmacist.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The most common adverse reactions with this medicine are dose dependent and related to its mode of action.
Stop taking this medicine and seek immediate medical help if you have any of the following symptoms:
- Modification in the heart functioning (the symptoms are a slowing down of the heart rate). They particularly occur within the first 2 to 3 months of treatment initiation
- Irregular rapid contraction of the heart
- Angioedema (such as swollen face, tongue or throat, difficulty in breathing or swallowing)
- Abnormal ECG heart tracing.
Other side effects have also been reported:
The frequency of possible side effects listed below is defined using the following convention:
Very common: (May affect more than 1 in 10 people)
Luminous visual phenomena (brief moments of increased
brightness, most often caused by sudden changes in light intensity). They can also be described as a halo, coloured flashes, image decomposition or multiple images. They generally occur within the first two months of treatment after which they may occur repeatedly and resolve during or after treatment. Common: (May affect up to 1 in 10 people)
- Abnormal perception of heartbeat
- Uncontrolled blood pressure
- Headache
- Dizziness
- Blurred vision (cloudy vision).
Uncommon: (May affect up to 1 in 100 people)
- Palpitations and cardiac extra beats
- Feeling sick (nausea) constipation
Diarrhoea
- Abdominal pain
- Spinning sensation (vertigo)
- Difficulty breathing (dyspnoea)
- Muscle spasms
- Changes in laboratory parameters: high blood levels of uric acid, an excess of eosinophils (a type of white blood cell) and elevated creatinine in blood (a breakdown product of muscle)
- skin rash
- Low blood pressure
- Fainting
- Feeling of tiredness
- Feeling of weakness
- Double vision
- impaired vision.
Rare: (May affect up to 1 in 1,000 people)
- Urticaria
- Itching
- Skin reddening
- Feeling unwell.
Very rare: (May affect up to 1 in 10,000 people)
- Irregular heartbeats.
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or searching for MHRA Yellow Card in the Google Play or Apple App Store.
By reporting side effects you can help provide more information on the safety of this medicine.
5. How to store Ivabradine
Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the carton and blister after 'EXP'. The expiry date refers to the last day of that month.
Store in the original package to protect from light.
Do not throw away any medicine via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
6. Contents of the pack and other information
What Ivabradine contains
The active substance is Ivabradine (as hydrochloride). 5mg - One film-coated tablet contains 5 mg of Ivabradine (equivalent to 5.390 mg as hydrochloride).
7.5 mg - One film-coated tablet contains 7.5 mg of Ivabradine (equivalent to 8.085 mg as hydrochloride).
The other ingredients in the tablet core are: lactose monohydrate, magnesium stearate, maize starch, maltodextrin (12), colloidal anhydrous silica, and in the tablet coating: hypromellose, titanium dioxide, macrogol (MW 6000), glycerol, iron oxide yellow, iron oxide red. What Ivabradine looks like and contents of the pack
Ivabradine 5 mg Film-coated tablets are Salmon-coloured, oblong, film-coated tablet scored on both sides, engraved with “5” on one face and plain on the other face.
Ivabradine 7.5 mg Film-coated tablets are Salmon-coloured, circular, film-coated tablet engraved with “7.5” on one face and plain on the other face.
Ivabradine 5mg and 7.5mg Film-coated tablets are available in aluminium (25 µm) and clear PVC (250 µm) blister packs of 14/28/ 56/100 tablets.
Not all pack sizes will be marketed.
To listen to or request a copy of this leaflet in Braille, large print or audio please call,
02088311580 (UK only)
Please be ready to give the following information:
Product name Reference number
Ivabradine 5mg PL 21880/0006 Film-coated Tablets
Ivabradine 7.5mg PL 21880/0205 Film-coated Tablets
Marketing Authorisation Holder and Manufacturer:
MEDREICH PLC
Warwick House, Plane Tree Crescent,
Feltham TW13 7HF, United Kingdom.
E-mail : info@medreich.co.uk
POM This leaflet was last revised in February 2024
1226995-V1